Greys Anatomy star Camilla Luddington diagnosed with Hashimoto disease, details inside
Speaking on the 'Call It What It Is' podcast, the 41-year-old revealed her diagnosis with Hashimoto's disease, as per People.
"Long as you've been listening to us, you've known that I joke about being slothy. Just a little slower. Slower, tired, wanna be in bed, love a nap. It never occurred to me that there could be a medical reason for that," she said at the time.
Luddington also shared that a few routine blood tests helped her find the diagnosis.
Noting that she initially thought it was some age or hormonal issues, the actress added, "And so I wanna say about two and a half months ago now, still very recent. Had blood work, and it came back. And my doctor was like, 'Everything looks great except this one little thing.'"
After hearing the words "autoimmune disease," Luddington was freaked out at first, but calmed down after the doctor assured her that the condition was "very common," she shared.
"I felt like I had the answer for something that I've known is going on. And I have health anxiety, so there was a part of me that was like, 'Am I gaslighting myself?'" she added.
Luddington said that her next move was to call Jessica Capshaw, her 'Grey's Anatomy' co-star and co-host on the podcast.
During the conversation, Luddington explained about the disease, stating that Hashimoto happens when the body's immune system accidentally attacks the thyroid, making one a little slothy. "So over time, the damage it does, it makes the thyroid slow down and stop making enough hormones," she said, further highlighting her symptoms of dry skin, hair loss, and weight gain.
The actress is now recovering, she assured. (ANI)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
FSSAI constitutes panel to review use of sugar in infant food
Synopsis Following criticism over added sugar in its Cerelac infant food, particularly in developing markets like India, the Food Safety and Standards Authority of India has formed a committee. This committee will assess the necessity of allowing sugar in infant food products. ANI Baby food sugar content (Image for representation) The Food Safety and Standards Authority of India has constituted a committee to assess whether India should allow infant food makers to add sugar to their products, said two people aware of the development comes after Nestle last year faced criticism for having added sugar in Cerelac, a popular infant food, in India and other developing markets. In the developed markets, the Swiss food and beverage company sells the product without sugar. India has a law covering ingredients of baby food and another for marketing. While the law strictly prohibits companies from marketing and promoting infant foods, companies are allowed to add sugar in the form of sucrose and to the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2019, "Sucrose and/or fructose shall not be added, unless needed as a carbohydrate source, and provided the sum of these does not exceed 20% of total carbohydrates."One of the persons cited earlier said on condition of anonymity, "The committee will assess if India should allow companies to add sugar to their infant food and if yes then how much." However, no deadline has been stipulated for the committee to submit its findings, according to the April 2024, Public Eye, a Swiss investigative organisation, and the International Baby Food Action Network alleged that Nestle added sugar to its Cerelac products in India and other developing markets, even as it sold the product without sugar in the developed India opposed the findings saying there was no difference between the products sold in India and in other its latest annual report, the company said it had reduced sugar in Cerelac up to 30% in the past five years and recently introduced a new Cerelac range with "no refined sugar" option.
News18
2 hours ago
- News18
Fermented food can personalise nutrition for Indias diverse population
New Delhi [India], August 15 (ANI): A study of population-specific responses to fermented food shows that the health effect of the bioactive peptides they contain differs across populations and can personalise nutrition for India's diverse population, the Ministry of Science and Technology said in a release on Thursday. Bioactive peptides from fermented foods are gaining global attention for their health benefits. With advancements in biotechnology and a deeper understanding of individual differences, bioactive peptides could hold great promise for nutrition and health solutions. A recent study conducted by the Institute of Advanced Study in Science and Technology (IASST), Guwahati, an autonomous institute of the Department of Science and Technology (DST), emphasises the health benefits of traditional fermented foods. They showed that the bioactive peptides (BAPs), or short protein fragments consisting of 2 to 20 amino acids, can regulate blood pressure, blood sugar, immunity, and inflammation. The study published in Food Chemistry (2025), led by Prof. Ashis K. Mukherjee, Corresponding author and Director IASST, Dr. Maloyjo Joyraj Bhattacharjee, Dr. Asis Bala, and Dr. Mojibr Khan showed that foods such as yogurt, idli, miso, natto, kimchi and fermented fish contain high levels of these peptides. These short peptides, formed during fermentation, interact with biomolecules through electrostatic forces, hydrogen bonding and hydrophobic interactions to exert antimicrobial, antihypertensive, antioxidant and immune-modulatory effects. This can influence cardiac function, immune response and metabolic health. However, their bioavailability and effectiveness vary across populations due to genetic polymorphisms, gut microbiota composition, dietary habits and health conditions. Gene variants in ACE or IL-6 may affect individual responses to these peptides. This data emphasises the necessity for precision nutrition and targeted health interventions customised to the diverse Indian population. The research published in the Journal of Food Chemistry can address challenges such as variability in fermentation methods, peptide stability and interactions with the microbiota. The study advocates incorporating traditional fermented foods into public health initiatives. It emphasises the need for omics-based (biological research that utilises high-throughput technologies to analyse large sets of molecules) research and innovation in rural food systems to establish India as a global leader in personalised nutrition, the release added. (ANI)
Hindustan Times
a day ago
- Hindustan Times
Man asks ChatGPT for health advice, lands in hospital with poisoning, psychosis
A ChatGPT-prescribed diet led a man to poisoning and an involuntary psychiatric hold, People magazine reported. The incident has prompted researchers to flag 'adverse health outcomes' that artificial intelligence (AI) can contribute to in today's time. The unidentified individual started having 'auditory and visual hallucinations' and even tried to escape the hospital.(Photo: Adobe Illustrator) Alarmed at the downside of table salt or sodium chloride, a 60-year-old man recently consulted ChatGPT for a substitute, according to a strange case that appeared in the journal Annals of Internal Medicine: Clinical Cases this month. While researchers were later unable to retrieve the man's prompts to ChatGPT, the AI chatbot advised the man to consume sodium bromide, as per People. Soon after he fell sick, the man rushed to a nearby hospital and claimed he had been poisoned. Following a blood report, the doctors at the hospital immediately transferred him to a telemetry bed for inspection. Also Read: OpenAI's Rocky GPT-5 Rollout Shows Struggle to Remain Undisputed AI Leader Man became paranoid of water As his health deteriorated, the person revealed he had taken dietary advice from ChatGPT and consumed sodium bromide. Although the 60-year-old was 'very thirsty', doctors found him to be 'paranoid about water.' After he started having 'auditory and visual hallucinations,' the man ran amok and tried to escape, which ultimately forced the hospital staff to place him on an involuntary psychiatric hold. He was finally discharged after three weeks of treatment. Also Read: ChatGPT model picker returns as GPT-5 rollout faces user feedback The US Centers for Disease Control informs that bromide can be used in agriculture or as a fire suppressant. While there are no available cures for bromine poisoning, survivors are likely to battle with long-term effects. FAQs: 1. Should I consult with AI for medical purposes? Since researchers have found consultation with AI on several topics can lead to 'promulgating decontextualized information,' you should always visit a licensed doctor for medical purposes. 2. What is sodium bromide? Sodium bromide is an inorganic compound that resembles table salt. It can cause headaches, dizziness and even psychosis. 3. What happened to the man who took sodium bromide after talks with ChatGPT? The man, who took sodium bromide after consultation with ChatGPT, suffered from paranoia and auditory and visual hallucinations. 4. Are there cures for bromine poisoning? There are no available cures for bromine poisoning.
